Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Debt Ratio (2022 - 2026)

TriSalus Life Sciences has reported Debt Ratio over the past 5 years, most recently at 0.47 for Q1 2026.

  • For Q1 2026, Debt Ratio fell 57.92% year-over-year to 0.47; the TTM value through Mar 2026 reached 0.47, down 57.92%, while the annual FY2025 figure was 0.94, 1.52% up from the prior year.
  • Debt Ratio for Q1 2026 was 0.47 at TriSalus Life Sciences, down from 0.94 in the prior quarter.
  • Over five years, Debt Ratio peaked at 1.11 in Q1 2025 and troughed at 0.11 in Q4 2022.
  • A 5-year average of 0.7 and a median of 0.79 in 2024 define the central range for Debt Ratio.
  • Biggest five-year swings in Debt Ratio: grew 19.01% in 2025 and later crashed 57.92% in 2026.
  • Year by year, Debt Ratio stood at 0.11 in 2022, then surged by 636.44% to 0.82 in 2023, then rose by 12.22% to 0.92 in 2024, then increased by 1.52% to 0.94 in 2025, then crashed by 50.17% to 0.47 in 2026.
  • Business Quant data shows Debt Ratio for TLSI at 0.47 in Q1 2026, 0.94 in Q4 2025, and 0.9 in Q3 2025.